Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc.) on March 26, 2013. The filing announces the consolidated financial results for the third quarter of fiscal year 2013. The report serves to furnish a press release (Exhibit 99.1) containing the detailed results.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the third quarter of fiscal year 2013 were announced.
Guidance, Outlook, and Risks
The text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. It explicitly states that the information in the report and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings unless expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, as the input metadata incorrectly listed "LIFECORE BIOMEDICAL, INC."
- Locate and review Exhibit 99.1 (Press Release dated March 26, 2013) to obtain actual financial figures for Q3 FY2013.
- Confirm the fiscal year end date for Landec Corporation to accurately interpret the "third quarter" reporting period.
- Note that this 8-K filing itself does not constitute a filed document for liability purposes under Section 18 of the Exchange Act.